---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-050995"
form_type: "8-K"
ticker: "OVID"
cik: "0001636651"
company_name: "Ovid Therapeutics Inc."
filed_at: "2023-10-02T23:59:59+00:00"
generated_at: "2026-06-10T06:22:47.778457+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Ovid Therapeutics posts R&D Day corporate presentation; no financial or clinical updates

## Summary
- Presentation posted Oct 2, 2023, on Ovid investor relations website.
- Slide titled 'Dawn of the neurotherapeutics era' by CEO Dr. Jeremy Levin.
- Filing exhibit includes only the cover slide; no detailed data disclosed.
- No material news regarding pipeline, financials, or guidance in this 8-K.

## SEC filing metadata
- accession: 0000950170-23-050995
- form_type: 8-K
- ticker: OVID
- cik: 0001636651
- company_name: Ovid Therapeutics Inc.
- filed_at: 2023-10-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636651/000095017023050995/0000950170-23-050995-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636651/000095017023050995/ovid-20231002.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-050995
- JSON: https://secwatch.observer/filing/0000950170-23-050995.json
- Plain text: https://secwatch.observer/filing/0000950170-23-050995.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.